Outset Medical Inc

Insider buying shows confidence in Outset Medical’s growth, with EVP Commercial Elliott Derick’s RSU grant hinting at future hemodialysis expansion and potential upside.

Outset Medical insider selling spikes: 1.9 M shares off the books after earnings, 24% drop, 38% monthly loss—what it signals for investors and the company’s valuation.

Outset Medical’s insider sell‑to‑cover by EVP Nash Marc shows routine tax liquidity, not a confidence shift, amid a 26 % weekly rally and rising social‑media buzz.